The effects of an evidence- and theory-informed feedback intervention on opioid prescribing for non-cancer pain in primary care: A controlled interrupted time series analysis

Sarah L Alderson, Tracey M Farragher, Thomas A Willis, Paul Carder, Stella Johnson, Robbie Foy, Sarah L Alderson, Tracey M Farragher, Thomas A Willis, Paul Carder, Stella Johnson, Robbie Foy

Abstract

Background: The rise in opioid prescribing in primary care represents a significant international public health challenge, associated with increased psychosocial problems, hospitalisations, and mortality. We evaluated the effects of a comparative feedback intervention with persuasive messaging and action planning on opioid prescribing in primary care.

Methods and findings: A quasi-experimental controlled interrupted time series analysis used anonymised, aggregated practice data from electronic health records and prescribing data from publicly available sources. The study included 316 intervention and 130 control primary care practices in the Yorkshire and Humber region, UK, serving 2.2 million and 1 million residents, respectively. We observed the number of adult patients prescribed opioid medication by practice between July 2013 and December 2017. We excluded adults with coded cancer or drug dependency. The intervention, the Campaign to Reduce Opioid Prescribing (CROP), entailed bimonthly, comparative, and practice-individualised feedback reports to practices, with persuasive messaging and suggested actions over 1 year. Outcomes comprised the number of adults per 1,000 adults per month prescribed any opioid (main outcome), prescribed strong opioids, prescribed opioids in high-risk groups, prescribed other analgesics, and referred to musculoskeletal services. The number of adults prescribed any opioid rose pre-intervention in both intervention and control practices, by 0.18 (95% CI 0.11, 0.25) and 0.36 (95% CI 0.27, 0.46) per 1,000 adults per month, respectively. During the intervention period, prescribing per 1,000 adults fell in intervention practices (change -0.11; 95% CI -0.30, -0.08) and continued rising in control practices (change 0.54; 95% CI 0.29, 0.78), with a difference of -0.65 per 1,000 patients (95% CI -0.96, -0.34), corresponding to 15,000 fewer patients prescribed opioids. These trends continued post-intervention, although at slower rates. Prescribing of strong opioids, total opioid prescriptions, and prescribing in high-risk patient groups also generally fell. Prescribing of other analgesics fell whilst musculoskeletal referrals did not rise. Effects were attenuated after feedback ceased. Study limitations include being limited to 1 region in the UK, possible coding errors in routine data, being unable to fully account for concurrent interventions, and uncertainties over how general practices actually used the feedback reports and whether reductions in prescribing were always clinically appropriate.

Conclusions: Repeated comparative feedback offers a promising and relatively efficient population-level approach to reduce opioid prescribing in primary care, including prescribing of strong opioids and prescribing in high-risk patient groups. Such feedback may also prompt clinicians to reconsider prescribing other medicines associated with chronic pain, without causing a rise in referrals to musculoskeletal clinics. Feedback may need to be sustained for maximum effect.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1. Mean number of adults prescribed…
Fig 1. Mean number of adults prescribed opioid per 1,000 adults: multilevel linear model estimates: Electronic health record data and denominator.
Adjusted for percent female, Quality and Outcomes Framework score, percentage of patients reporting a positive experience of their practice, percentage of patients with long-term conditions, and Index of Multiple Deprivation. Black line = intervention practices; grey line = control practices.

References

    1. Kiang MV, Humphreys K, Cullen MR, Basu S. Opioid prescribing patterns among medical providers in the United States, 2003–17: retrospective, observational study. BMJ. 2020;368:l6968. doi: 10.1136/bmj.l6968
    1. Kalkman GA, Kramers C, van Dongen RT, van den Brink W, Schellekens A. Trends in use and misuse of opioids in the Netherlands: a retrospective, multi-source database study. Lancet Public Health. 2019;4(10):E498–505. doi: 10.1016/S2468-2667(19)30128-8
    1. Fredheim OMS, Mahic M, Skurtveit S, Dale O, Romundstad P, Borchgrevink PC. Chronic pain and use of opioids: a population-based pharmacoepidemiological study from the Norwegian Prescription Database and the Nord-Trøndelag Health Study. Pain. 2014;155(7):1213–21. doi: 10.1016/j.pain.2014.03.009
    1. Lalic S, Gisev N, Bell JS, Korhonen MJ, Ilomäki J. Predictors of persistent prescription opioid analgesic use among people without cancer in Australia. Br J Clin Pharmacol. 2018;84(6):1267–78. doi: 10.1111/bcp.13556
    1. Rosner B, Neicun J, Yang JC, Roman-Urrestarazu A. Opioid prescription patterns in Germany and the global opioid epidemic: systematic review of available evidence. PLoS ONE. 2019;14(8):e0221153. doi: 10.1371/journal.pone.0221153
    1. Jeffery MM, Hooten WM, Henk HJ, Bellolio MF, Hess EP, Meara E, et al.. Trends in opioid use in commercially insured and Medicare Advantage populations in 2007–16: retrospective cohort study. BMJ. 2018;362:k2833. doi: 10.1136/bmj.k2833
    1. Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med. 2003;349(20):1943–53. doi: 10.1056/NEJMra025411
    1. Berterame S, Erthal J, Thomas J, Fellner S, Vosse B, Clare P, et al.. Use of and barriers to access to opioid analgesics: a worldwide, regional, and national study. Lancet. 2016;387(10028):1644–56. doi: 10.1016/S0140-6736(16)00161-6
    1. Ray WA, Chung CP, Murray KT, Hall K, Stein C. Prescription of long-acting opioids and mortality in patients with chronic noncancer pain. JAMA. 2016;315(22):2415–23. doi: 10.1001/jama.2016.7789
    1. Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain—United States, 2016. JAMA. 2016;315(15):1624–45. doi: 10.1001/jama.2016.1464
    1. Krebs EE, Gravely A, Nugent S, Jensen AC, DeRonne B, Goldsmith ES, et al.. Effect of opioid vs nonopioid medications on pain-related function in patients with chronic back pain or hip or knee osteoarthritis pain: the space randomized clinical trial. JAMA. 2018;319(9):872–82. doi: 10.1001/jama.2018.0899
    1. Jani M, Birlie Yimer B, Sheppard T, Lunt M, Dixon WG. Time trends and prescribing patterns of opioid drugs in UK primary care patients with non-cancer pain: a retrospective cohort study. PLoS Med. 2020;17(10):e1003270. doi: 10.1371/journal.pmed.1003270
    1. Schieber LZ, Guy GP Jr, Seth P, Young R, Mattson CL, Mikosz CA, et al.. Trends and patterns of geographic variation in opioid prescribing practices by state, United States, 2006–2017. JAMA Netw Open. 2019;2(3):e190665. doi: 10.1001/jamanetworkopen.2019.0665
    1. Verhamme KMC, Bohnen AM. Are we facing an opioid crisis in Europe? Lancet Public Health. 2019;4(10):e483–4. doi: 10.1016/S2468-2667(19)30156-2
    1. Curtis HJ, Croker R, Walker AJ, Richards GC, Quinlan J, Goldacre B. Opioid prescribing trends and geographical variation in England, 1998–2018: a retrospective database study. Lancet Psychiatry. 2019;6(2):140–50. doi: 10.1016/S2215-0366(18)30471-1
    1. Foy R, Leaman B, McCrorie C, Petty D, House A, Bennett M, et al.. Prescribed opioids in primary care: cross-sectional and longitudinal analyses of influence of patient and practice characteristics. BMJ Open. 2016;6(5):e010276. doi: 10.1136/bmjopen-2015-010276
    1. Zin CS, Chen L-C, Knaggs RD. Changes in trends and pattern of strong opioid prescribing in primary care. Eur J Pain. 2014;18(9):1343–51. doi: 10.1002/j.1532-2149.2014.496.x
    1. Eccleston C, Fisher E, Thomas KH, Hearn L, Derry S, Stannard C, et al.. Interventions for the reduction of prescribed opioid use in chronic non-cancer pain. Cochrane Database Syst Rev. 2017;11(11):CD010323. doi: 10.1002/14651858.CD010323.pub3
    1. Katzman JG, Qualls CR, Satterfield WA, Kistin M, Hofmann K, Greenberg N, et al.. Army and navy ECHO pain telementoring improves clinician opioid prescribing for military patients: an observational cohort study. J Gen Intern Med. 2019;34(3):387–95. doi: 10.1007/s11606-018-4710-5
    1. Liebschutz JM, Xuan Z, Shanahan CW, LaRochelle M, Keosaian J, Beers D, et al.. Improving adherence to long-term opioid therapy guidelines to reduce opioid misuse in primary care: a cluster-randomized clinical trial. JAMA Intern Med. 2017;177(9):1265–72. doi: 10.1001/jamainternmed.2017.2468
    1. Samet JH, Tsui JI, Cheng DM, Liebschutz JM, Lira MC, Walley AY, et al.. Improving the delivery of chronic opioid therapy among people living with human immunodeficiency virus: a cluster randomized clinical trial. Clin Infect Dis. 2020Jul22. doi: 10.1093/cid/ciaa1025
    1. Ivers N, Jamtvedt G, Flottorp S, Young JM, Odgaard‐Jensen J, French SD, et al.. Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev. 2012;6:CD000259. doi: 10.1002/14651858.CD000259.pub3
    1. Race Disparity Unit. Regional ethnic diversity. ; 2020 [cited 2021 Sep 16]. Available from: .
    1. Department for Communities and Local Government. The English indices of deprivation 2010: statistical release. London: Department for Communities and Local Government; 2011.
    1. Shadish WR, Cook TD, Campbell DT. Experimental and quasi-experimental designs for generalized causal inference. Boston: Houghton Mifflin; 2002. doi: 10.1037/1082-989x.7.1.3
    1. Fretheim A, Zhang F, Ross-Degnan D, Oxman AD, Cheyne H, Foy R, et al.. A reanalysis of cluster randomized trials showed interrupted time-series studies were valuable in health system evaluation. J Clin Epidemiol. 2015;68(3):324. doi: 10.1016/j.jclinepi.2014.10.003
    1. Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002;27(4):299–309. doi: 10.1046/j.1365-2710.2002.00430.x
    1. Glidewell L, Willis TA, Petty D, Lawton R, McEachan RRC, Ingleson E, et al.. To what extent can behaviour change techniques be identified within an adaptable implementation package for primary care? A prospective directed content analysis. Implement Sci. 2018;13(1):32. doi: 10.1186/s13012-017-0704-7
    1. Willis TA, Collinson M, Glidewell L, Farrin AJ, Holland M, Meads D, et al.. An adaptable implementation package targeting evidence-based indicators in primary care: a pragmatic cluster-randomised evaluation. PLoS Med. 2020;17(2):e1003045. doi: 10.1371/journal.pmed.1003045
    1. Brehaut JC, Colquhoun HL, Eva KW, Carroll K, Sales A, Michie S, et al.. Practice feedback interventions: 15 suggestions for optimizing effectiveness. Ann Intern Med. 2016;164(6):435–41. doi: 10.7326/M15-2248
    1. McLintock K, Russell AM, Alderson SL, West R, House A, Westerman K, et al.. The effects of financial incentives for case finding for depression in patients with diabetes and coronary heart disease: interrupted time series analysis. BMJ Open. 2014;4(8):e005178. doi: 10.1136/bmjopen-2014-005178
    1. EBM DataLab. OpenPrescribing. Oxford: University of Oxford; 2017.
    1. Public Health England. National general practice profiles. London: Public Health England; 2021 [cited 2021 Sep 16]. Available from: .
    1. Doran T, Fullwood C, Gravelle H, Reeves D, Kontopantelis E, Hiroeh U, et al.. Pay-for-performance programs in family practices in the United Kingdom. N Engl J Med. 2006;355(4):375–84. doi: 10.1056/NEJMsa055505
    1. Lopez Bernal J, Cummins S, Gasparrini A. The use of controls in interrupted time series studies of public health interventions. Int J Epidemiol. 2018;47(6):2082–93. doi: 10.1093/ije/dyy135
    1. Hudson J, Fielding S, Ramsay CR. Methodology and reporting characteristics of studies using interrupted time series design in healthcare. BMC Med Res Methodol. 2019;19(1):137. doi: 10.1186/s12874-019-0777-x
    1. Turner SL, Karahalios A, Forbes AB, Taljaard M, Grimshaw JM, Korevaar E, et al.. Creating effective interrupted time series graphs: review and recommendations. Res Synth Methods. 2021;12(1):106–17. doi: 10.1002/jrsm.1435
    1. Reid MC, Henderson CR, Papaleontiou M, Amanfo L, Olkhovskaya Y, Moore AA, et al.. Characteristics of older adults receiving opioids in primary care: treatment duration and outcomes. Pain Med. 2010;11(7):1063–71. doi: 10.1111/j.1526-4637.2010.00883.x
    1. Daoust R, Paquet J, Moore L, Émond M, Gosselin S, Lavigne G, et al.. Recent opioid use and fall-related injury among older patients with trauma. CMAJ. 2018;190(16):E500–6. doi: 10.1503/cmaj.171286
    1. Chapman EJ, Edwards Z, Boland JW, Maddocks M, Fettes L, Malia C, et al.. Practice review: evidence-based and effective management of pain in patients with advanced cancer. Palliat Med. 2020;34(4):444–53. doi: 10.1177/0269216319896955
    1. Tadrous M, Greaves S, Martins D, Nadeem K, Singh S, Mamdani MM, et al.. Evaluation of the fentanyl patch-for-patch program in Ontario, Canada. Int J Drug Policy. 2019;66:82–6. doi: 10.1016/j.drugpo.2019.01.025
    1. Chen T-C, Chen L-C, Knaggs RD. A 15-year overview of increasing tramadol utilisation and associated mortality and the impact of tramadol classification in the United Kingdom. Pharmacoepidemiol Drug Saf. 2018;27:487–94. doi: 10.1002/pds.4320
    1. Curtis HJ, Goldacre B. OpenPrescribing: normalised data and software tool to research trends in English NHS primary care prescribing 1998–2016. BMJ Open. 2018;8(2):e019921. doi: 10.1136/bmjopen-2017-019921
    1. Hallsworth M, Chadborn T, Sallis A, Sanders M, Berry D, Greaves F, et al.. Provision of social norm feedback to high prescribers of antibiotics in general practice: a pragmatic national randomised controlled trial. Lancet. 2016;387(10029):P1743–52. doi: 10.1016/S0140-6736(16)00215-4
    1. Guthrie B, Kavanagh K, Robertson C, Barnett K, Treweek S, Petrie D, et al.. Data feedback and behavioural change intervention to improve primary care prescribing safety (EFIPPS): multicentre, three arm, cluster randomised controlled trial. BMJ. 2016;354:i4079. doi: 10.1136/bmj.i4079
    1. Brown B, Gude WT, Blakeman T, van der Veer SN, Ivers N, Francis JJ, et al.. Clinical Performance Feedback Intervention Theory (CP-FIT): a new theory for designing, implementing, and evaluating feedback in health care based on a systematic review and meta-synthesis of qualitative research. Implement Sci. 2019;14(1):40. doi: 10.1186/s13012-019-0883-5
    1. Desveaux L, Saragosa M, Kithulegoda N, Ivers NM. Understanding the behavioural determinants of opioid prescribing among family physicians: a qualitative study. BMC Fam Pract. 2019;20(1):59. doi: 10.1186/s12875-019-0947-2
    1. Mordecai L, Reynolds C, Donaldson LJ, de C Williams AC. Patterns of regional variation of opioid prescribing in primary care in England: a retrospective observational study. Br J Gen Pract. 2018;68(668):e225–33. doi: 10.3399/bjgp18X695057
    1. Gornall J. Exposed: national disgrace as a quarter of a million patients are turned into drug addicts by their doctors. The Daily Mail. 2017Mar28.
    1. Rhodes D. NHS accused of fuelling rise in opioid addiction. BBC News. 2018 Mar 15 [cited 2021 Sep 20]. Available from: .
    1. Ferlie EB, Shortell SM. Improving the quality of health care in the United Kingdom and the United States: a framework for change. Milbank Q. 2001;79(2):281–315. doi: 10.1111/1468-0009.00206
    1. Grimshaw J, Ivers N, Linklater S, Foy R, Francis JJ, Gude WT, et al.. Reinvigorating stagnant science: implementation laboratories and a meta-laboratory to efficiently advance the science of audit and feedback. BMJ Qual Saf. 2019;28(5):416–23. doi: 10.1136/bmjqs-2018-008355

Source: PubMed

3
購読する